Community/Retail

OTC Product News from PT Retail March 2021.

The APhA and the CDC announced that they have entered into a collaborative agreement focused on supporting the role of pharmacists in building the public’s confidence in COVID-19 vaccines.

The studies had a minimum follow-up period of 24 weeks and reported at least 1 event of breast cancer or benign breast neoplasm, which included 90,360 participants.

The researchers used cross-sectional surveys, which were conducted with a convenience sample of rural community pharmacists who were part of a rural community pharmacy practice-based research network.

Daily national surveys by Carnegie Mellon University (CMU) show that although COVID-19 vaccine uptake has increased, the proportion of vaccine-hesitant adults has remained unchanged.

A prognostic COVID-19 Severity Test has been launched for the identification of high-risk individuals who are likely to experience the most severe COVID-19 complications upon exposure to the virus.

In an interview with Pharmacy Times, Sandra Leal, PharmD, MPH, FAPhA, CDE, said pharmacists along the United States-Mexico border must consider the unique needs of their patients, including those with language barriers or those in underserved populations.

The STEP1 study included 1961 adults with a body mass index (BMI) of 27 or higher with at least 1 weight-related health condition, or a BMI of 30 or higher, without diabetes.

Researchers found no evidence that protection against COVID-19 reinfection declined within a 6-month follow-up period.

As the pandemic has continued, it has helped shine a light on how important pharmacists, pharmacy interns, and pharmacy technicians can help impact their communities.

Pharmacy Times spoke with Josh Benner, pharmacist and CEO/founder of RxAnte, about medication misuse and the future of pharmacy in 2021.

Caroline Carney, MD, MSc, FAPM, CPHQ, CMO of Magellan Health, discusses how pharmacists and other medical professionals can boost their brain health and keep a positive mindset while working during the pandemic.

Trust between a physician and pharmacist is essential to the overall quality of patient-centered care.

Although ART has helped improve the health of those with HIV, they are at a greater risk of developing complications related to chronic inflammation, such as cardiovascular disease.

The plot clinical trial included 40 men and is believed to be the first published study to use progesterone to treat male COVID-19 patients whose lung functions have been compromised by the virus.

Shoulder injuries are a real concern because some health care workers may be new to administering vaccines.

Farah Towfic, PharmD, MBA, director, CEO operations at US Pharmacopeia (USP), discusses USP’s release of an updated version of its COVID-19 Vaccine Handling Toolkit in response to feedback from independent pharmacies to mass vaccination clinics.

The COVID-19 pandemic significantly impacted pharmacy practice due to its role in supporting overwhelmed physicians, nurses, and other health care professionals who faced some of the immediate challenges of the crisis.

Pharmacies can reach patients who are not receiving vaccines from a pharmacy but are willing to receive them.

More than ever, confidence in objective, science-based data about therapeutics, such as the COVID-19 vaccine and other health care services, is a shared imperative across the pharmaceutical industry, health care communities, and the American public.

New results show that non-Hispanic Black patients with COVID-19 and type 1 diabetes have an additional risk of diabetic ketoacidosis beyond the risk of having diabetes or being of minority status.

Use basic knowledge of medications to be the first line of defense in ensuring safety and maintaining pharmacy workflow.

Among surveyed American adults, more than half were diagnosable with probable depression at baseline, in addition to 65% who had anxiety and 51% at risk for post-traumatic stress disorder.

Exposure to fine particulate, carbon monoxide, and ozone over time was linked to increased methylation, leading to higher rates of heart disease and other conditions in adulthood.

The researchers analyzed body composition data from the National Health and Nutrition Examination Survey (1999-2004) and cardiovascular disease data from the National Health and Nutrition Examination Survey (1999-2014).

Following a review of the latest interim data released by AstraZeneca on its US phase 3 clinical trial assessing the 2-dose AZD1222 COVID-19 vaccine, the Data and Safety Monitoring Board (DSMB) expressed concern at the inclusion of what may have been outdated data.

Intranasal administration of virucidal and antiviral therapies may provide added clinical benefit by decreasing viral activity in the nasal pathway, preventing COVID-19 transmission and managing disease severity.

This was the first genome-wide association study of skin pigmentation in African Americans, according to the study authors.